← Back to Search

Vaccine

COPD for Chronic Obstructive Pulmonary Disease

Phase 4
Waitlist Available
Research Sponsored by Banner Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

To evaluate the magnitude of the humoral immune responses to quadrivalent vs trivalent influenza vaccines in adults between the age of 50 and 64 years with a prior diagnosis of GOLD Stage C and D COPD vs. those patients without COPD.

Eligible Conditions
  • Chronic Obstructive Pulmonary Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hemagglutination inhibiting antibodies (HI) against the components of viral antigens

Trial Design

2Treatment groups
Active Control
Group I: COPDActive Control1 Intervention
Group will receive either the Fluzone Trivalent or Fluzone Quadrivalent.
Group II: ControlActive Control1 Intervention
Group will receive either the Fluzone Trivalent or Fluzone Quadrivalent.

Find a Location

Who is running the clinical trial?

Banner HealthLead Sponsor
22 Previous Clinical Trials
1,005,158 Total Patients Enrolled
Sanofi Pasteur, a Sanofi CompanyIndustry Sponsor
407 Previous Clinical Trials
6,091,881 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Seasonal Influenza Vaccine, Quadrivalent Versus Trivalent in Patients With Advanced Chronic Obstructive Pulmonary Disease
David Baratz, M.D. 2015. "Seasonal Influenza Vaccine, Quadrivalent Versus Trivalent in Patients With Advanced Chronic Obstructive Pulmonary Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02563184.
All > Osa > Influenza
~10 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top